These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10559581)

  • 1. Effects of cyclosporin A on immune activation markers in patients with active psoriasis.
    Economidou J; Barkis J; Demetriou Z; Avgerinou G; Psarra K; Degiannis D; Vareltzidis A; Katsambas A
    Dermatology; 1999; 199(2):144-8. PubMed ID: 10559581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
    De Rie MA; Zonneveld IM; Witkamp L; Van Lier RA; Out TA; Bos JD
    Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis: comparison of immunological markers in patients with acute and remission phase.
    De Pità O; Ruffelli M; Cadoni S; Frezzolini A; Biava GF; Simom R; Bottari V; De Sanctis G
    J Dermatol Sci; 1996 Nov; 13(2):118-24. PubMed ID: 8953411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy.
    Thomson AW; Nalesnik MA; Rilo HR; Woo J; Carroll PB; Van Thiel DH
    Autoimmunity; 1993; 15(3):215-23. PubMed ID: 7505632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
    Hingorani M; Calder VL; Buckley RJ; Lightman S
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological stress, endocrine and immune response in patients with lichen planus.
    Krasowska D; Pietrzak A; Surdacka A; Tuszyńska-Bogucka V; Janowski K; Roliński J
    Int J Dermatol; 2008 Nov; 47(11):1126-34. PubMed ID: 18986442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)/IgG1 fusion protein alefacept.
    Larsen R; Ryder LP; Svejgaard A; Gniadecki R
    Clin Exp Immunol; 2007 Jul; 149(1):23-30. PubMed ID: 17403057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD4 monoclonal antibody therapy in severe psoriasis.
    Morel P; Revillard JP; Nicolas JF; Wijdenes J; Rizova H; Thivolet J
    J Autoimmun; 1992 Aug; 5(4):465-77. PubMed ID: 1384529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes.
    Härtel C; Hammers HJ; Schlenke P; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
    J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation.
    Gottlieb AB; Grossman RM; Khandke L; Carter DM; Sehgal PB; Fu SM; Granelli-Piperno A; Rivas M; Barazani L; Krueger JG
    J Invest Dermatol; 1992 Mar; 98(3):302-9. PubMed ID: 1372027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of psoriasis with a topical cyclosporin A formulation.
    Duncan JI; Wakeel RA; Winfield AJ; Ormerod AD; Thomson AW
    Acta Derm Venereol; 1993 Apr; 73(2):84-7. PubMed ID: 8103272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
    Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
    Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.
    Tahvili S; Zandieh B; Amirghofran Z
    Int J Dermatol; 2015 Jul; 54(7):e254-60. PubMed ID: 26108267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial clinical effects of cyclosporin A on severe psoriasis and its dissociation from serum concentration of soluble interleukin-2 receptor, soluble interleukin-6 receptor, soluble CD14 antigen, soluble intercellular adhesion molecule-1, and soluble vascular cell adhesion molecule-1.
    Yamamoto T; Kimura K; Katayama I; Koyano T; Mamada A; Miyazaki K; Irimajiri T; Furuse Y; Nishioka K
    Arch Dermatol Res; 1996 Dec; 289(1):57-9. PubMed ID: 9017138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative changes in CD4+ and CD8+ T-lymphocytes in the skin of patients with psoriasis treated with cyclosporin A].
    Adamicová K; Fetisovová Z; Cingel P; Péc J; Parobeková K; Chromej I
    Cesk Patol; 2001 Nov; 37(4):154-7. PubMed ID: 11813632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble IL-2 receptor and CD25 cells in psoriasis: effects of cyclosporin A and PUVA therapy.
    Duncan JI; Horrocks C; Ormerod AD; Powles AV; Whiting PH; Fry L; Thomson AW
    Clin Exp Immunol; 1991 Aug; 85(2):293-6. PubMed ID: 1864010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in T-cell phenotype and adhesion molecules expression in psoriatic lesions after low-dose cyclosporin therapy.
    Servitje O; Bordas X; Serón D; Vidaller A; Moreno A; Curcó N; Sais G; Peyrí J
    J Cutan Pathol; 1996 Oct; 23(5):431-6. PubMed ID: 8915851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.